The US is easing restrictions on cannabis. What could it mean for San Diego?

The Biden administration is officially moving to reclassify cannabis from a Schedule I drug to Schedule III. We talk about how it will impact research and the industry. Plus, what the future holds for cannabis equity in San Diego.

Related Keywords

California ,United States ,Israel ,San Diego ,Toronto ,Ontario ,Canada ,Colorado ,Meaghan Mccall ,Mark Wallace ,Thomas Marcotte ,Jackie Bryant ,Meagan Mccall ,Uc San Diego Center ,Research Advisory Panel Of California ,Drug Administration ,Us Drug Enforcement Administration ,Climate Equity Fund ,Major League ,Google ,Supreme Court ,Toronto Stock Exchange ,Medicinal Cannabis Research ,Midday Edition ,Enforcement Administration ,Likei Ve ,Toronto Stock ,Im Jade ,Doctor Thomas ,Medicinal Cannabis ,Doctor Marcotte ,Compassionate Use ,Igor Grant ,Research Advisory Panel ,Doctor Thomas Marcotte ,Diego Center ,President Biden ,Climate Equity ,City Hall ,Navy November ,